Siglec-3IgE

Suzanne M Barshow1, Maidul Islam2, Scott Commins3

  • 1Duke University School of Medicine, Durham, NC; University of North Carolina at Chapel Hill, Chapel Hill, NC.

概括

研究人员开发了抗IgE-CD33L,以抑制人类基细胞的脱粒化. 这种新型结合物通过向IgE-FcεRI通路,有效抑制过敏反应,提供潜在的过敏治疗方法.